Covered recipient · General Payments record
ALISON MACLEOD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,464.86
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $539.44 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $151.97 | 8 |
| Lilly USA, LLC | $93.98 | 4 |
| Novo Nordisk AS | $63.93 | 3 |
| PFIZER INC. | $52.43 | 3 |
| Astellas Pharma US Inc | $42.84 | 2 |
| Janssen Pharmaceuticals, Inc | $37.66 | 2 |
| Biogen, Inc. | $29.49 | 1 |
| ViiV Healthcare Company | $26.90 | 1 |
| SHIELD THERAPEUTICS INC | $23.52 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $16.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.61 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573832 | CMS |
| ABBVIE INC. | $19.04 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573834 | CMS |
| ABBVIE INC. | $14.19 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573836 | CMS |
| ABBVIE INC. | $21.58 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573838 | CMS |
| ABBVIE INC. | $14.85 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573840 | CMS |
| ABBVIE INC. | $24.99 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573842 | CMS |
| ABBVIE INC. | $19.85 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573844 | CMS |
| ABBVIE INC. | $19.86 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573846 | CMS |
| Astellas Pharma US Inc | $26.16 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139492656 | CMS |
| Astellas Pharma US Inc | $16.68 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139529760 | CMS |
| Biogen, Inc. | $29.49 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104847904 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $16.72 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146792648 | CMS |
| Janssen Pharmaceuticals, Inc | $17.87 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078180107 | CMS |
| Janssen Pharmaceuticals, Inc | $19.79 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078180105 | CMS |
| Lilly USA, LLC | $25.78 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135520723 | CMS |
| Lilly USA, LLC | $23.52 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135514828 | CMS |
| Lilly USA, LLC | $21.30 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135525833 | CMS |
| Lilly USA, LLC | $23.38 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135514830 | CMS |
| Novo Nordisk Inc | $23.33 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100293808 | CMS |
| Novo Nordisk Inc | $14.88 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100528167 | CMS |
| Novo Nordisk Inc | $25.72 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100227364 | CMS |
| PFIZER INC. | $20.82 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131242746 | CMS |
| PFIZER INC. | $13.79 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131637317 | CMS |
| PFIZER INC. | $17.82 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131023800 | CMS |
| SHIELD THERAPEUTICS INC | $23.52 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150134737 | CMS |
| ViiV Healthcare Company | $26.90 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112709512 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.